Orthonotes Logo
Orthonotes
by the.bonestories

Fibrous Dysplasia — Shepherd’s Crook

3 Views

Category: Tumor

Share Wiki QR Card Download Slides (.pptx)
Developmental fibro‑osseous lesion replacing normal bone with fibrous tissue. Types: monostotic (70%), polyostotic; associated with McCune–Albright (café‑au‑lait, endocrine). X‑ray: ground‑glass appearance, expansion, cortical thinning; Shepherd’s crook deformity of proximal femur. Histology: irregular woven bone trabeculae (‘Chinese letters’) in fibrous stroma. Treatment: bisphosphonates for pain, corrective osteotomies, internal fixation for deformity.
Published Feb 28, 2026 • Author: The Bone Stories ✅
🧠 Test Yourself with OrthoMind AI

10 AI-generated high-yield questions by our AI engine



Overview & Epidemiology

Fibrous dysplasia (FD) is a benign skeletal condition in which normal medullary bone is replaced by abnormal fibrous tissue containing poorly mineralised woven bone trabeculae. It results from a post-zygotic activating mutation in the GNAS gene (encoding the Gs-alpha subunit of G-protein), which leads to unregulated osteoblastic differentiation and abnormal bone production. Despite being non-hereditary, fibrous dysplasia can cause significant skeletal deformity, pain, and pathological fractures, particularly in the proximal femur.

  • GNAS gene mutation (Arg201His or Arg201Cys): activating somatic mutation; occurs post-zygotically — severity and distribution depends on timing of mutation during embryogenesis (mosaic distribution)
  • Monostotic FD (70–80%): single bone involved; most commonly proximal femur, tibia, ribs, skull base, facial bones; discovered incidentally or after fracture
  • Polyostotic FD (20–30%): multiple bones; typically unilateral (hemimelic) distribution; more severe deformity; diagnosed in childhood
  • McCune-Albright syndrome: polyostotic FD + café-au-lait spots (coast of Maine borders) + endocrine hyperfunctioning (precocious puberty most common); café-au-lait spots in McCune-Albright are large, irregular, with jagged borders — distinct from neurofibromatosis spots which have smooth borders
  • Mazabraud syndrome: FD + intramuscular myxomas (rare association)
  • Malignant transformation: rare (<1% in monostotic; up to 4% in polyostotic; higher post-radiation) — most commonly to osteosarcoma; rapid growth or sudden pain warrants biopsy
Pathology
  • Medullary bone replaced by cellular fibrous stroma containing irregularly shaped woven bone trabeculae without osteoblastic rimming
  • Classic histological description: "Chinese characters" or "alphabet soup" pattern — curved, irregularly shaped woven bone trabeculae within cellular fibrous stroma; absence of osteoblastic rimming is key
  • Cartilage islands: present in some lesions (fibrocartilaginous dysplasia variant) — do not indicate malignancy
  • Affected bone: cortex thinned but usually intact; medullary cavity expanded; bone structurally weak and deformable
  • The abnormal fibrous tissue cannot mineralise normally — this is why the bone remains structurally weak throughout life and deforms under load
Radiological Features
  • Ground-glass matrix: classic radiological appearance — homogeneous, hazy density of affected medullary bone resembling frosted glass; reflects the poorly mineralised fibrous tissue replacing normal bone
  • Well-defined lesion with narrow zone of transition; endosteal scalloping; cortex thinned but generally intact; no periosteal reaction (unless fracture)
  • Expansile lesion with cortical thinning — characteristic "rind" of thinned cortex around ground-glass interior
  • Shepherd crook deformity: characteristic varus deformity of the proximal femur — repeated microfractures and plastic deformity of the femoral neck cause progressive varus, eventually producing a hook-shaped proximal femur resembling a shepherd crook; almost pathognomonic of fibrous dysplasia involving the proximal femur
  • Bone scan: intense uptake in affected areas — useful for mapping extent of polyostotic disease
  • MRI: variable signal (low T1; variable T2 depending on proportion of fibrous tissue vs cartilage vs cystic change); useful for assessing cortical integrity and soft tissue involvement
Clinical Presentation
  • Wide spectrum from asymptomatic (incidental finding) to severe deformity with recurrent fractures and chronic pain
  • Proximal femur: most clinically significant location — progressive varus deformity (shepherd crook), limb length discrepancy, pathological fractures of the femoral neck; Trendelenburg gait from coxa vara
  • Facial involvement: facial asymmetry, proptosis, visual compromise, hearing loss from skull base/orbital involvement; lion face (leontiasis ossea) in severe polyostotic disease
  • Biochemistry: usually normal; elevated alkaline phosphatase in extensive polyostotic disease; phosphate wasting in some — FGF23 elevated (similar mechanism to XLH)
  • McCune-Albright: girls present with vaginal bleeding and breast development before age 8 years (precocious puberty); assess with pelvic ultrasound and endocrine evaluation
  • Worsening during pregnancy: FD lesions may enlarge and become more painful during pregnancy — oestrogen-responsive pathology
Management — Non-Operative
  • Observation: asymptomatic monostotic disease with no deformity or fracture risk — observe with serial radiographs; many lesions stabilise at skeletal maturity
  • Bisphosphonates (pamidronate IV): reduce pain and bone turnover in FD; some evidence of radiological improvement; do NOT cure FD but can reduce fracture pain and ALP; most evidence for IV pamidronate — oral bisphosphonates less well studied in FD
  • Pain management: NSAIDs; bisphosphonates; neuropathic agents for bone pain; opioids for acute fracture pain
  • Endocrine management in McCune-Albright: aromatase inhibitors or testolactone for precocious puberty; endocrinology co-management essential
  • Activity modification: avoid high-impact activities that stress weakened bones; physiotherapy to optimise gait mechanics and muscle strength
Management — Surgical

Surgical intervention is indicated for pathological fractures, impending fractures, progressive deformity, and painful lesions failing conservative management. The fundamental principle of surgical management differs from standard fracture fixation.

  • Key surgical principle: FD bone does not remodel normally — bone graft placed into FD lesions is resorbed and replaced by abnormal fibrous tissue; autograft and allograft behave identically poorly in FD cavities; cortical allograft slightly better than cancellous
  • PMMA cement preferred over bone graft in FD — cement is not remodelled and provides durable fill; however, cement should be combined with internal fixation for structural support
  • Proximal femur FD (shepherd crook deformity):
Scenario Surgical Management
Impending fracture without deformity Prophylactic intramedullary nail (cephalomedullary nail); curettage and cement optional
Femoral neck fracture Internal fixation with dynamic hip screw or cephalomedullary nail; curettage if accessible
Established shepherd crook deformity Valgus osteotomy of proximal femur + intramedullary fixation (long nail spanning lesion); curettage and cement of proximal femur lesion; correct varus mechanically
Tibial or other long bone lesion Intramedullary nail or plate fixation; curettage optional; cement or allograft cortical strut
  • Intramedullary nailing is preferred over plating for FD — spanning the entire lesion with an IM nail provides superior load-sharing and reduces fracture risk at stress risers beyond the implant
  • Curettage alone without fixation: only for small contained lesions in non-weight-bearing bones; not sufficient for weight-bearing long bones
  • Growing children: use flexible nails or fixation that can be revised; account for ongoing growth
Consultant-Level Considerations
  • Avoid radiation: post-radiation sarcomatous transformation is a well-documented risk in FD — radiation should never be used; treat with surgery and medical management only
  • Malignant transformation in FD: sudden increase in pain or rapid radiological change in a known FD lesion = biopsy urgently; osteosarcoma is most common secondary malignancy; fibrosarcoma and undifferentiated pleomorphic sarcoma also described; overall rate <1% monostotic, higher polyostotic
  • Phosphate wasting in FD: FGF23 produced by abnormal stromal cells → renal phosphate wasting → secondary rickets-like picture; in extensive polyostotic disease this can be clinically significant; monitor renal tubular phosphate handling; treat with phosphate supplementation ± calcitriol as in XLH
  • Bisphosphonate use caution: bisphosphonates inhibit osteoclast activity — theoretically beneficial but some evidence they harden FD bone and make surgical curettage more technically difficult; plan surgery before or early in bisphosphonate course if surgical intervention anticipated
  • Craniofacial FD: managed by craniofacial surgeons; surgical debulking for cosmesis or functional compromise (visual loss, airway); timing controversial — stabilisation at skeletal maturity preferred before surgery as lesions may grow until then; optic canal decompression is urgent if visual acuity threatened
Exam Pearls
  • GNAS activating mutation (Gs-alpha); somatic, post-zygotic; mosaic distribution; not hereditary
  • Ground-glass matrix on X-ray = classic fibrous dysplasia appearance
  • Shepherd crook deformity: varus proximal femur from repeated microfractures; almost pathognomonic of proximal femoral FD
  • McCune-Albright: polyostotic FD + café-au-lait (jagged borders) + endocrine hyperfunction (precocious puberty)
  • Chinese characters histology: curved woven bone trabeculae WITHOUT osteoblastic rimming — key distinguishing histological feature
  • Bone graft does NOT work in FD — resorbed and replaced by fibrous tissue; PMMA cement preferred
  • IM nail preferred over plate — spans lesion, reduces stress riser fracture risk
  • Shepherd crook correction: valgus osteotomy + long cephalomedullary nail spanning whole lesion
  • Radiation contraindicated — risk of post-radiation sarcoma
  • Malignant transformation <1% monostotic; sudden pain change = urgent biopsy; osteosarcoma most common
🧠 Test Yourself with OrthoMind AI

10 AI-generated high-yield questions by our AI engine

References

Bianco P et al. Fibrous dysplasia. N Engl J Med. 2001;344(18):1381–1389.
DiCaprio MR, Enneking WF. Fibrous dysplasia: pathophysiology, evaluation, and treatment. J Bone Joint Surg Am. 2005;87(8):1848–1864.
Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet. 1994;343(8903):953–954.
Collins MT et al. An epidemiological approach to fibrous dysplasia and the McCune-Albright syndrome. Orphanet J Rare Dis. 2012.
Chapurlat RD, Meunier PJ. Fibrous dysplasia of bone. Baillieres Best Pract Res Clin Rheumatol. 2000;14(2):385–398.
Leet AI, Collins MT. Current approach to fibrous dysplasia of bone and McCune-Albright syndrome. J Child Orthop. 2007;1(1):3–17.
Ippolito E et al. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthop B. 2003.
Campbells Operative Orthopaedics. 14th Edition. Elsevier.
Orthobullets — Fibrous Dysplasia.
Enneking WF, Gearen PF. Fibrous dysplasia of the femoral neck: treatment by cortical bone grafting. J Bone Joint Surg Am. 1986;68(9):1415–1422.